Amgen (AMGN) PT Raised to $280 at Oppenheimer on Positive Sotorasib Study
Tweet Send to a Friend
(Updated - October 6, 2020 7:03 AM EDT)(updated to add analyst comments)Oppenheimer analyst Jay Olson raised the price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
